Drugs that rate on Twitter

Posted 25 February 2021 AM

Three drugs have been revealed as the most actively discussed and hashtagged on Twitter in the area of inflammatory arthritic diseases, according to a new drug watch analysis.

Pfizer's tofacitinib, sold under the brand name Xeljanz,  AbbVie's upadacitinib sold as Rinvoq and Gilead's filgotinib sold as Jyseleca have been "hot topics" of discussion with many patients curious about new approvals and the impact of  the immune-suppressing drugs and COVID-19.

Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here